Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology

Money

Sealantis Sells for $25 Million

February 6, 2019
AlgaeIndustryMagazine.com

The Sealantis team. Photo: Nitzan Zohar, Technion spokesperson’s office

Sealantis, which was established in Israel on the basis of technology developed at the Technion Institute, has been sold for US$25 million and royalties from future sales to Advanced Medical Solutions Group from England.

Sealantis develops medical adhesives based on technology from the Technion, which mimics the mechanism of adhesion of algae to rocks in water. “This is fundamental research inspired by a natural phenomenon that developed into applied technology, was patented and eventually became a product that will enable hundreds of thousands of patients to be treated.”

AMS, the acquiring company, is a manufacturer of innovative and technologically advanced products for the global surgical, wound closure and advanced wound care markets. This is their first acquisition in Israel, and Sealantis will be an innovation center for the multinational group. AMS’s products are sold in more than 75 countries, and the group has more than 600 employees.

Sealantis develops medical device products, based on a proprietary platform of alga-mimetic tissue adhesives, for a variety of applications in surgical adhesion. The company was established under the auspices of the AMIT Institute at the Technion, under the leadership of Prof. Havazelet Bianco-Peled, a world-renowned expert in biomedical polymers, from the Faculty of Chemical Engineering at the Technion.

The company’s present focus is on surgical seals designed to stop bleeding, prevent leakage of digestive tract contents into the abdominal cavity, prevent leakage of spinal fluid, and a variety of other applications.

The leading advantage of the technology is the fact that it is based on a polymer produced from algae, which does not contain proteins, and therefore the risk of infection or allergy is significantly lower than that of competing products produced from animals. The product does not require refrigerated transport and storage, it can be applied by spreading or spraying and is also suitable for use in laparoscopic surgery.

Tomer Fuchs, CEO of Sealantis, said that the connection with AMS increases the potential impact of the company’s products. “The journey of Sealantis is underway. The merger into AMS is an important milestone in the realization of our vision to enable medical teams around the world to prevent serious surgical complications thanks to Sealantis’ products.

“Following the merger, AMS will enjoy our scientific and engineering capabilities as an Israeli start-up company in the field of biotechnology, which includes innovation and the ability to bring simple and original solutions to complex challenges. AMS plans to expand operations in Israel, enabling it to expand into new, significant directions.”

More Like This…

Copyright ©2010-2019 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Steve Fountain writes in fortstocktonpioneer.com that, amid the 800-page law that last month set the country’s farm policy through 2023, is the expansion of federal suppo...
Dartmouth scientists have created a more sustainable feed for aquaculture by using a marine microalga co-product as a feed ingredient. The study is the first of its kind ...
The Utah Science Technology and Research (USTAR) initiative, a technology-based economic development program funded by the state of Utah, has awarded a $175,320 grant for...
Foodbev.com reports that French marine ingredients company Algaia will install a new specialty seaweed extract unit at its facility in Brittany, France, after securing €4...
Judith Lewis Mernit writes in e360.yale.edu that an experiment being conducted by animal science professor Ermias Kebreab at the University of California, Davis, is testi...
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
Environmental Technology magazine notes that the difficulty in predicting how algae blooms will develop lies in their variform nature. With a multitude of different bloom...
Algae and corals have been leaning on each other since dinosaurs roamed the earth, much longer than had been previously thought, according to new research led by scientis...
Alexander Richter writes in thinkgeoenergy.com that Israel-based Algaennovation last week signed a 15-year contract with Icelandic energy utility and operator ON Power fo...
How did plants make the evolutionary jump from water to land? Scientists think that green algae are their water-living ancestors, but we are not sure how the transition t...
Globally, an increase in water pollution is pushing scientists and environmental care specialists to seek best ways of preserving and maintaining sources of safe drinking...
Paris-based Solabia Group (“Solabia”) has acquired Algatech Ltd., a global leader in the development, cultivation and commercialization of ingredients delivered from micr...